The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Medical resource utilization among multiple myeloma (MM) patients who were triple-exposed to a proteasome inhibitor, an immunomodulatory agent, and daratumumab.
 
Maneesha Mehra
Employment - Janssen
 
Concetta Crivera
Employment - Janssen Scientific Affairs
 
Satish Valluri
Employment - Janssen
 
Sandhya Nair
Employment - Janssen
 
Martin Vogel
Employment - Janssen-Cilag
 
Tonia Nesheiwat
Employment - Legend Biotech
 
Ravi C. Potluri
Employment - SmartAnalyst
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Helsinn Therapeutics (Inst); Janssen (Inst)
 
Sundar Jagannath
Honoraria - Celgene; Karyopharm Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst)
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group